Medication-info.com Search Menu

Utebzi (Tebipenem pivoxil): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
300 mg
Active ingredient:

Patient information: uses, side effects, how to take - Utebzi

What is UTEBZI?

  • UTEBZI is a carbapenem antibiotic used to treat adults who have an infection of the bladder or kidneys (known as a complicated urinary tract infection [cUTI]) caused by certain types of bacteria.
  • It is not known if UTEBZI is safe and effective in children under 18 years of age.

Do not take UTEBZI if you:

  • are allergic to UTEBZI, similar antibiotics (such as carbapenems, penicillins, cephalosporins), or any of the ingredients in UTEBZI. See the end of this Patient Information leaflet for a complete list of ingredients in UTEBZI.
  • have low levels of a substance in the body called carnitine (carnitine deficiency) or have certain conditions that cause low levels of carnitine. UTEBZI can decrease the level of carnitine in your body.

Before you take UTEBZI, tell your healthcare provider about all of your medical conditions, including if you:

  • have a history of brain problems, such as seizures or tumors.
  • have kidney problems or you are on dialysis.
  • are pregnant or plan to become pregnant. It is not known if UTEBZI can harm your unborn baby.

    Pregnancy Safety Study: There is a pregnancy safety study for women who are or become pregnant during treatment with UTEBZI. The purpose of this pregnancy safety study is to collect information about your health and your baby’s health. You or your healthcare provider can report your pregnancy by calling 1-888-825-5249.

  • are breastfeeding or plan to breastfeed. It is not known if UTEBZI passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take UTEBZI.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. UTEBZI and certain other medicines may interact with each other. This may cause serious side effects.

Especially tell your healthcare provider if you take:

  • probenecid
  • valproic acid or divalproex sodium

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

How should I take UTEBZI?

  • Always take UTEBZI exactly as your healthcare provider has told you to. Check with your healthcare provider if you are not sure.
  • The dose of UTEBZI is 2 tablets taken by mouth, every 6 hours for 7 to 10 days. If you have kidney problems your dose may be different.
  • Swallow UTEBZI whole, with or without food.

  • If you miss a dose of UTEBZI, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and take the medicine at your regularly scheduled time. Do not take a double dose to make up for a missed dose.
  • If you take too many UTEBZI tablets, call your healthcare provider or Poison Help line at 1-800-222-1222, or go to the nearest hospital emergency room right away.

UTEBZI is only for infections caused by bacteria. It is not for infections caused by viruses, such as the common cold. It is important that you take the full course of UTEBZI. Do not stop taking UTEBZI unless your healthcare provider tells you to (even if you are feeling better). If you do not complete the full course of treatment with UTEBZI, the infection may come back.

What are the possible side effects of UTEBZI?

UTEBZI can cause serious side effects, including:

  • Allergic (hypersensitivity) reactions: Allergic reactions can happen after you take UTEBZI. Serious allergic reactions, including those leading to death have happened with antibiotics similar to UTEBZI. See “Do not take UTEBZI if you:”. Tell your healthcare provider if you have had an allergic reaction to antibiotics such as carbapenems, penicillins, cephalosporins, or other beta-lactam medicines in the past. These medicines are similar to UTEBZI. Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure.
  • Central Nervous System (CNS) problems: Seizures and other CNS problems have been reported in people who take UTEBZI or similar antibiotics, including carbapenems, penicillins, and cephalosporins. Tell your healthcare provider if you get any of the following side effects, or other changes in your brain function, mood or behavior during treatment with UTEBZI:
  1. ○ seizures
  2. ○ confusion
  1. ○ tremors
  2. ○ feeling lightheaded or dizzy

Your healthcare provider may decide to stop treatment with UTEBZI.

  • Carnitine deficiency: Levels of a substance in the body called carnitine may decrease while taking UTEBZI. See “Do not take UTEBZI if you:”. Contact your healthcare provider right away if you have any of the following signs or symptoms:
  1. ○ fainting
  2. ○ confusion
  3. ○ worsening tiredness (fatigue)
  1. ○ muscle aches and weakness
  2. ○ seizures
  1. ○ low blood sugar (hypoglycemia). Lightheadedness, dizziness, shakiness, or hunger may happen if your blood sugar is too low.
  • Diarrhea: Diarrhea is a common side effect caused by antibiotics, including UTEBZI. The diarrhea usually stops after the antibiotic is stopped. In some cases, diarrhea may be caused by Clostridioides difficile infection (CDI). CDI is a severe infection of the intestines (bowels) that can happen over 2 months after finishing treatment with antibiotic medicines, including UTEBZI. CDI can be life‑threatening and can lead to death. Do not take medicines to treat diarrhea without checking first with your healthcare provider. Contact your healthcare provider right away if you have any of the following signs or symptoms:
  1. ○ stomach cramps
  2. ○ fever
  3. ○ watery diarrhea
  1. ○ diarrhea that does not go away
  2. ○ bloody stools
  • If you are pregnant and taking UTEBZI, this may cause a false-positive screening test result for a substance called isovaleric acid in your newborn baby.

The most common side effects of UTEBZI include:

  • diarrhea
  • headache
  • nausea
  • stomach pain
  • increase in liver enzymes
  • Clostridioides difficile infection (CDI)

These are not all the possible side effects of UTEBZI.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store UTEBZI?

  • Store UTEBZI at room temperature between 68°F to 77°F (20°C to 25°C).

Keep UTEBZI and all medicines out of the reach of children.

General information about the safe and effective use of UTEBZI.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not take UTEBZI for a condition for which it was not prescribed. Do not give UTEBZI to other people, even if they have the same symptoms that you have. It may harm them.

You can ask your healthcare provider or pharmacist for information about UTEBZI that is written for health professionals.

What are the ingredients in UTEBZI?

Active ingredients: tebipenem pivoxil (as tebipenem pivoxil hydrobromide).

Inactive ingredients: crospovidone, magnesium stearate, microcrystalline cellulose and silicon dioxide.

Tablet film-coating: FD&C blue 1, polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide and yellow iron oxide.

For more information about UTEBZI, call 1-888-825-5249 or go to www.gsk.com.

Trademarks are owned by or licensed to the GSK group of companies.

GlaxoSmithKline, Durham, NC 27701

©2026 GSK group of companies or its licensor.

UTB:1PIL

This Patient Information has been approved by the U.S. Food and Drug Administration Issued: June 2026

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 215960 · View the label on DailyMed

Revision date stated in the text: June 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Utebzi

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Active ingredient Tebipenem pivoxil 300 mg
Dosage form Tablet, film coated
Route Oral
Marketing status listed in the FDA NDC Directory
Company (applicant) GLAXOSMITHKLINE
FDA approval NDA 215960New Drug Application (NDA) Approved June 17, 2026
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
300 mg – 8 in 1 blister pack / 10 in 1 carton NDC 0173-0956-07

Source: FDA drug labeling via NLM DailyMed, data as of November 16, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.